Point of Care Diagnostic Market Growth, Size, Trends Forecast 2030
Point-of-care (POC) diagnostics Market
Overview:
Point-of-care
(POC) diagnostics Market refers to diagnostic testing that is performed at
or near the location where the patient is being treated. This type of testing
allows for quick and convenient testing, and is typically performed using
portable or handheld devices that can produce results in a matter of minutes.
The Point of
Care Diagnostic Market was analyzed which was worth USD 35.4 Billion in the
year 2021, expecting a CAGR of 7.03% during the forecast period (2022-2030),
and the market is projected to be valued at USD 65.25 Billion by 2030.
POC testing
is performed in a variety of settings, including hospitals, clinics, and in the
home. The tests can be used to diagnose a range of conditions, including
infectious diseases, chronic conditions, and pregnancy, among others. POC
diagnostics is particularly useful in emergency and critical care settings,
where rapid diagnosis and treatment are essential.
Get Sample Report Here: https://marketresearchcommunity.com/sample-request/?rid=2193
The growth
of the point-of-care diagnostic market is driven by the increasing incidence of
chronic diseases, growing demand for rapid and accurate diagnoses, and the
increasing adoption of POC devices. The market is expected to continue to grow
in the coming years, as the demand for POC testing continues to increase and
technological advances in POC testing continue to be made.
The goal of
POC testing is to speed up the diagnostic process, reduce the time to
treatment, and improve patient outcomes. By providing rapid results, POC
testing can help healthcare providers to make more informed decisions about
treatment and management of patients.
Point-of-care (POC) diagnostics Market
Includes Key Players:
·
Johnson
and Johnson
·
Siemens
AG
·
Nova
Biomedical
·
Danaher
Corporation
·
bioMrieux
SA
·
Abbott
Laboratories
·
Hoffmann
La Roche Ltd
·
Sinocare
Inc.
·
Sysmex
corporation
·
Becton
Dickinson and Company
The
Point-of-care (POC) diagnostics market is segmented into various Product,
Purchase, Platform, End User including Sub segments such as:
·
By Product: Glucose Monitoring Products,
Infectious Disease Testing Products, Coagulation Monitoring Products, Fecal
Occult Testing Products, Cardiometabolic Monitoring Products, Pregnancy &
Fertility Testing Products, Cholesterol Testing Products, Cancer Marker Testing
Products, Urinalysis Testing Products, Haematology Testing Products, Drugs-of-abuse
Testing Products, Other POC Products
·
By Purchase: OTC Testing Products,
Prescription-based Testing Products
·
By Platform: Lateral Flow Assays, Immunoassays,
Microfluidics, Molecular Diagnostics, Dipsticks
·
By End User:
Professional Diagnostic Centers, Research Laboratories, Home Care,
Others
·
By Geography: North America, Europe, Asia Pacific,
Latin America, the Middle East, and Africa
Geographically,
the market is segmented into North America, Europe, Asia-Pacific, Latin
America, and Middle East & Africa. North America is expected to hold the
largest Point-of-care (POC) diagnostics
Market Share, due to
the high incidence of chronic diseases, increasing demand for rapid and accurate
diagnoses, and a strong healthcare infrastructure. Asia-Pacific is expected to
grow at the highest rate, due to the increasing adoption of POC devices, the
growing number of diagnostic laboratories, and the increasing healthcare
spending in the region.
Market Research Community
Email: sales@marketresearchcommunity.com
Comments
Post a Comment